Risks and benefits of phase 1 oncology trials, revisited

被引：65
|
作者：
Kurzrock, R
Benjamin, RS
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Div Canc Med, Phase 1 Program, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Div Canc Med, Dept Sarcoma Med Oncol, Houston, TX 77030 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2005年 / 352卷 / 09期
关键词：
D O I：
10.1056/NEJMe058007
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：930 / 932
页数：3
相关论文
共 50 条
  • [1] Risks and benefits of phase 1 oncology trials, 1991 through 2002
    Horstmann, E
    McCabe, MS
    Grochow, L
    Yamamoto, S
    Rubinstein, L
    Budd, T
    Shoemaker, D
    Emanuel, EJ
    Grady, C
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (09): : 895 - 904
  • [2] Risks and benefits of phase 1 oncology trials in the era of personalized medicine
    Chakiba, Camille
    Grellety, Thomas
    Cousin, Sophie
    Italiano, Antoine
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [3] Descriptions of benefits and risks in consent forms for phase 1 oncology trials
    Horng, S
    Emanuel, EJ
    Wilfond, B
    Rackoff, J
    Martz, K
    Grady, C
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (26): : 2134 - 2140
  • [4] Risks and benefits of phase 1 oncology trials in the era of personalized medicine
    Chakiba, C.
    Grellety, T.
    Cousin, S.
    Italiano, A.
    ANNALS OF ONCOLOGY, 2016, 27
  • [5] Risks and benefits of phase 1 oncology trials, 2001 through 2012.
    Fukuda, Yoko Korenaga
    Huang, Erich
    Finnigan, Shanda
    Ivy, S. Percy
    Rubinstein, Larry
    Takebe, Naoko
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [6] Phase I oncology trials: risks and benefits vary by trial type
    Reactions Weekly, 2005, 1042 (1) : 5 - 5
  • [7] Communication about the risks and benefits of phase I pediatric oncology trials
    Hazen, Rebecca A.
    Zyzanski, Stephen
    Baker, Justin N.
    Drotar, Dennis
    Kodish, Eric
    CONTEMPORARY CLINICAL TRIALS, 2015, 41 : 139 - 145
  • [8] Benefits (survival) and risks (30 days mortality) of phase I trials in oncology
    Djulbegovic, B.
    Moreno, C.
    Kumar, A.
    Lush, R.
    Munster, P. N.
    Daud, A. I.
    Garrett, C. R.
    Simon, G. R.
    Lancet, J. E.
    Sullivan, D. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] Clinical benefits and risks of phase I oncology trials: experience from a single institution
    Gollamudi, R.
    Wong, B. M.
    Ghalib, M. H.
    Kumar, M.
    Desai, K.
    Chaudhary, I.
    Goel, S.
    Mani, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [10] Risks and benefits associated with novel phase 1 oncology trial designs
    Koyfman, Shlomo A.
    Agrawal, Manish
    Garreft-Mayer, Elizabeth
    Krohmal, Benjamin
    Wolf, Elizabeth
    Emanuel, Ezekiel J.
    Gross, Cary P.
    CANCER, 2007, 110 (05) : 1115 - 1124
12345